These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4654661)

  • 1. Cycloalkane spiroheterocyclic compounds. 9. 8-(1,2,3,4-Tetrahydro-2-naphthyl)-2-oxo-1-oxa-3,8-diazaspiro(4.5)decanes and related compounds.
    Maillard J; Langlois M; Delaunay P; Van TV; Chenu J; Morin R; Benharkate M; Manuel C; Motosso F
    J Med Chem; 1972 Nov; 15(11):1123-8. PubMed ID: 4654661
    [No Abstract]   [Full Text] [Related]  

  • 2. 8-(1-Naphthalen-2-yl-vinyl)-6,7,10-trioxaspiro (4.5) decane, a new 1,2,4-trioxane effective against rodent and simian malaria.
    Singh C; Kanchan R; Srivastava D; Puri SK
    Bioorg Med Chem Lett; 2006 Feb; 16(3):584-6. PubMed ID: 16275088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanes.
    Mehrotra MM; Heath JA; Rose JW; Smyth MS; Seroogy J; Volkots DL; Ruhter G; Schotten T; Alaimo L; Park G; Pandey A; Scarborough RM
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1103-7. PubMed ID: 11909727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists.
    Tsukamoto S; Nagaoka H; Igarashi S; Wanibuchi F; Hidaka K; Tamura T
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1523-9. PubMed ID: 7586076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiarrhythmic activity of 2,2-dialkyl-1'-(N-substituted aminoalkyl)-spiro-(chroman-4,4'-imidazolidine)-2',5'-diones.
    Matsukura M; Daiku Y; Ueda K; Tanaka S; Igarashi T; Minami N
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1823-7. PubMed ID: 1394698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonists.
    Mehrotra MM; Heath JA; Smyth MS; Pandey A; Rose JW; Seroogy JM; Volkots DL; Nannizzi-Alaimo L; Park GL; Lambing JL; Hollenbach SJ; Scarborough RM
    J Med Chem; 2004 Apr; 47(8):2037-61. PubMed ID: 15056002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regioselective synthesis of polycyclic aza-oxa and aza-oxa-thia heteroarenes as Colo-205 and HepG2 carcinoma cells growth inhibitors.
    Maurya HK; Gautam SK; Pratap R; Tandon VK; Kumar A; Kumar B; Saxena S; Tripathi D; Rajwanshi M; Das M; Ram VJ
    Eur J Med Chem; 2014 Jun; 81():367-77. PubMed ID: 24858542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-HIV1 biological activity of novel 5''-ATSAO compounds.
    Tomassi C; Nguyen Van Nhien A; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Postel D
    Bioorg Med Chem; 2008 Apr; 16(8):4733-41. PubMed ID: 18316194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of sulfonamides and 9-oxo-2,8-diazaspiro[5,5]undecane-2-carboxamides as human kynurenine aminotransferase 2 (KAT2) inhibitors.
    Kalliokoski T; Rummakko P; Rantanen M; Blaesse M; Augustin M; Ummenthala GR; Choudhary S; Venäläinen J
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127060. PubMed ID: 32113843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticonvulsant properties of a series of N-substituted 2-aza-spiro[4.5]decane-1,3-diones and 8-phenyl-2-aza-spiro[4.5]decane-1,3-diones.
    Obniska J
    Acta Pol Pharm; 2004; 61(6):467-72. PubMed ID: 15794340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of azaspirocycles and their evaluation in drug discovery.
    Burkhard JA; Wagner B; Fischer H; Schuler F; Müller K; Carreira EM
    Angew Chem Int Ed Engl; 2010 May; 49(20):3524-7. PubMed ID: 20544904
    [No Abstract]   [Full Text] [Related]  

  • 12. 3-Azaspiro[5.5]undecanes.
    Petigara RB; Deliwala CV
    J Med Chem; 1969 Nov; 12(6):1088-9. PubMed ID: 5351451
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereocontrolled syntheses of epimeric 3-aryl-6-phenyl-1-oxa-7-azaspiro(4.5)decane NK-1 receptor antagonist precursors.
    Kulagowski JJ; Curtis NR; Swain CJ; Williams BJ
    Org Lett; 2001 Mar; 3(5):667-70. PubMed ID: 11259032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of dispiro peroxides against Fasciola hepatica.
    Wang X; Zhao Q; Vargas M; Dong Y; Sriraghavan K; Keiser J; Vennerstrom JL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5320-3. PubMed ID: 21802291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antihypertensive activity of a series of 8-substituted 1-oxa-3,8-diazaspiro[4.5]decan-2-ones.
    Caroon JM; Clark RD; Kluge AF; Nelson JT; Strosberg AM; Unger SH; Michel AD; Whiting RL
    J Med Chem; 1981 Nov; 24(11):1320-8. PubMed ID: 7310808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of spirocyclic scaffolds in drug discovery.
    Zheng Y; Tice CM; Singh SB
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3673-82. PubMed ID: 25052427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis of some bridgehead N,O-heterocycles of biological interest.
    Kourounakis P; Hunter WH; Morris PG
    Arzneimittelforschung; 1979; 29(7):983-6. PubMed ID: 583001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic and biological studies on the spiro-mamakone system.
    Murphy AC; Devenish SR; Muscroft-Taylor AC; Blunt JW; Munro MH
    Org Biomol Chem; 2008 Oct; 6(20):3854-62. PubMed ID: 18843418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of spiro[tetralin-2,2'-pyrrolidine] and spiro[indan-2,2'-pyrrolidine] derivatives as potential analgesics.
    Crooks PA; Rosenberg HE
    J Med Chem; 1978 Jun; 21(6):585-7. PubMed ID: 671457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic studies on heterocyclic natural products.
    Ciufolini MA
    Farmaco; 2005 Aug; 60(8):627-41. PubMed ID: 16095596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.